HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $702,004 | -41.6% | 8,225 | -55.5% | 0.00% | -57.1% |
| Q2 2022 | $1,203,000 | -58.3% | 18,463 | -59.5% | 0.01% | -53.3% |
| Q1 2022 | $2,883,000 | -22.6% | 45,607 | -35.0% | 0.02% | -21.1% |
| Q4 2021 | $3,724,000 | -29.5% | 70,207 | -6.2% | 0.02% | -34.5% |
| Q3 2021 | $5,284,000 | -34.6% | 74,853 | -38.3% | 0.03% | -37.0% |
| Q2 2021 | $8,081,000 | -76.9% | 121,257 | -61.6% | 0.05% | -79.1% |
| Q1 2021 | $35,050,000 | -10.1% | 315,739 | -3.8% | 0.22% | -10.6% |
| Q4 2020 | $38,982,000 | +3.9% | 328,266 | -23.6% | 0.25% | -13.7% |
| Q3 2020 | $37,502,000 | +4954.2% | 429,825 | +5676.4% | 0.28% | +3462.5% |
| Q1 2020 | $742,000 | +194.4% | 7,441 | +158.7% | 0.01% | +100.0% |
| Q1 2019 | $252,000 | -48.9% | 2,876 | -66.1% | 0.00% | -66.7% |
| Q4 2017 | $493,000 | – | 8,491 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |